In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of RXO Inc (NYSE: RXO) closed at $16.34 in the last session, down -1.51% from day before closing price of $16.59. In other words, the price has decreased by -$1.51 from its previous closing price. On the day, 1.4 million shares were traded. RXO stock price reached its highest trading level at $17.01 during the session, while it also had its lowest trading level at $16.34.
Ratios:
We take a closer look at RXO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.35 and its Current Ratio is at 1.35. In the meantime, Its Debt-to-Equity ratio is 0.43 whereas as Long-Term Debt/Eq ratio is at 0.37.
On March 13, 2025, Truist started tracking the stock assigning a Buy rating and target price of $24.
On March 07, 2025, Deutsche Bank started tracking the stock assigning a Hold rating and target price of $19.Deutsche Bank initiated its Hold rating on March 07, 2025, with a $19 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 14 ’25 when Szlosek Thomas A bought 7,500 shares for $16.65 per share. The transaction valued at 124,875 led to the insider holds 16,200 shares of the business.
Szlosek Thomas A bought 8,700 shares of RXO for $125,354 on May 09 ’25. The Director now owns 8,700 shares after completing the transaction at $14.41 per share. On Nov 12 ’24, another insider, Nettles Michelle, who serves as the Director of the company, bought 1,800 shares for $27.89 each. As a result, the insider paid 50,202 and bolstered with 15,185 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RXO now has a Market Capitalization of 2720548352 and an Enterprise Value of 3340551424. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.48 while its Price-to-Book (P/B) ratio in mrq is 1.69. Its current Enterprise Value per Revenue stands at 0.601 whereas that against EBITDA is 24.384.
Stock Price History:
The Beta on a monthly basis for RXO is 1.42, which has changed by -0.43983543 over the last 52 weeks, in comparison to a change of 0.1443547 over the same period for the S&P500. Over the past 52 weeks, RXO has reached a high of $31.98, while it has fallen to a 52-week low of $12.19. The 50-Day Moving Average of the stock is 1.93%, while the 200-Day Moving Average is calculated to be -8.09%.
Shares Statistics:
According to the various share statistics, RXO traded on average about 1.92M shares per day over the past 3-months and 1684130 shares per day over the past 10 days. A total of 163.97M shares are outstanding, with a floating share count of 160.58M. Insiders hold about 2.08% of the company’s shares, while institutions hold 105.81% stake in the company. Shares short for RXO as of 1759190400 were 11717796 with a Short Ratio of 6.09, compared to 1756425600 on 7917682. Therefore, it implies a Short% of Shares Outstanding of 11717796 and a Short% of Float of 19.99.
Earnings Estimates
The firm’s stock currently is rated by 20.0 analysts. The consensus estimate for the next quarter is $0.07, with high estimates of $0.09 and low estimates of $0.05.
Analysts are recommending an EPS of between $0.15 and $0.07 for the fiscal current year, implying an average EPS of $0.12. EPS for the following year is $0.37, with 20.0 analysts recommending between $0.67 and $0.21.
Revenue Estimates
According to 17 analysts,. The current quarter’s revenue is expected to be $1.43B. It ranges from a high estimate of $1.49B to a low estimate of $1.39B. As of. The current estimate, RXO Inc’s year-ago sales were $1.04BFor the next quarter, 17 analysts are estimating revenue of $1.56B. There is a high estimate of $1.66B for the next quarter, whereas the lowest estimate is $1.41B.
A total of 19 analysts have provided revenue estimates for RXO’s current fiscal year. The highest revenue estimate was $6.06B, while the lowest revenue estimate was $5.66B, resulting in an average revenue estimate of $5.86B. In the same quarter a year ago, actual revenue was $4.55BBased on 19 analysts’ estimates, the company’s revenue will be $6.21B in the next fiscal year. The high estimate is $6.62B and the low estimate is $5.74B.
